Secretome Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- November 25, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $20,400,000
Company Info
- Traction
- The funding will enable Secretome to initiate clinical trials for its lead asset, STM-01.
- Company Description
- Secretome Therapeutics is a biotechnology company advancing therapies derived from neonatal cardiac progenitor cells (nCPCs).
- Market
- Therapeutics
- Location
- Dallas, TX, USA